CUA 2017: Role of Androgen Deprivation in Salvage Radiotherapy

Toronto, Ontairo ( Dr. Tamim Niazi, from McGill University provided an excellent summary of the literature on the role for androgen-deprivation therapy (ADT) in patients undergoing salvage radiotherapy (RT).

CUA 2017: Intraductal Prostate Cancer: Marker of Aggressive Disease?

Toronto, Ontario ( Dr. Van der Kwast, a recognized uro-pathologist from the Princess Margaret Cancer Centre (PMCC), gave an excellent talk regarding the clinical implications of finding intraductal prostate cancer (IPC) and cribriform pattern on prostate pathology (radical prostatectomy or prostate biopsy). 

CUA 2017: Liquid Biopsy in Personalizing CRPC Therapy.

Toronto, Ontario ( Dr. Kim Chi started the 5th Annual CUA-Canadian Urologic Oncology Group (CUOG) Multidisciplinary meeting by reviewing the latest updates regarding liquid biopsy in castration resistant prostate cancer (CRPC) therapy. Dr. Chi notes that the treatment spectrum in the CRPC setting has rapidly developed over the last decade, subsequently increasing the prevalence of men with CRPC as these treatments prolong overall survival.